【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Assumptions
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Markers used for diagnosis of solid tumors
PART 05: Cost analysis
PART 06: Pipeline portfolio
• Anticipated number of products with single and multiple indications by 2020
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: Market segmentation by molecule type
• Small molecules
• Biologics
PART 09: Market segmentation by type of therapy
• Chemotherapy
• Hormone therapy
• Targeted therapy
• Immunotherapy
PART 10: Market segmentation by disease
• Global breast cancer drugs market
• Global NHL drugs market
• Global colorectal cancer drugs market
• Global NSCLC drugs market
• Global prostate cancer drugs market
• Global kidney cancer drugs market
• Global retinoblastoma drugs market
• Global cervical cancer market
• Global melanoma drugs market
• Global gastric cancer drugs market
• Global pancreatic cancer drugs market
• Global ovarian cancer drugs market
• Global liver cancer drugs market
• Global HL drugs market
• Global glioblastoma multiforme drugs market
PART 11: Geographical segmentation
• Solid tumors drugs market in Americas
• Solid tumors drugs market in EMEA
• Solid tumors drugs market in APAC
PART 12: Market drivers
• Patient assistance programs
• Exposure to risk factors
• Provision for rare diseases
• Promising pipeline
• Increase in prevalence of solid tumors
PART 13: Impact of drivers
PART 14: Market challenges
• Patent expiration of top-selling drugs
• Poor diagnosis and screening
• High cost of drugs
• Availability of chemotherapy and off-label drugs
• Stringent regulations
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Increase in cancer awareness
• Emergence of targeted and combination therapies
• Emergence of biosimilars
• Joint ventures and partnerships for R&D
• Increase in use of brachytherapy
PART 17: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• F. Hoffmann-La Roche
• Novartis
• Celgene
• Johnson & Johnson
• Pfizer
• BMS
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Types of solid tumors
Exhibit 03: Markers used for types of solid tumors
Exhibit 04: Annual treatment cost per patient for solid tumor drugs 2014
Exhibit 05: Average cost of surgeries associated with solid tumors 2014 ($)
Exhibit 06: Average cost of chemotherapy 2014 ($)
Exhibit 07: Average cost of radiation therapy 2014 ($)
Exhibit 08: Phase III pipeline molecules for solid tumors
Exhibit 09: Phase II pipeline molecules for solid tumors
Exhibit 10: Phase I pipeline molecules for solid tumors
Exhibit 11: Pre-clinical pipeline molecules for solid tumors
Exhibit 12: Pipeline share of solid tumors drugs 2015
Exhibit 13: Near-launch immuno-oncology pipeline assets 2020
Exhibit 14: Global solid tumors market 2015-2020 ($ billions)
Exhibit 15: Factors influencing global solid tumors drugs market 2015
Exhibit 16: Five forces analysis
Exhibit 17: Segmentation of global solid tumors drugs market by type of molecules 2015
Exhibit 18: Market segmentation by disease
Exhibit 19: Global solid tumors drugs market: Segmentation by disease 2015
Exhibit 20: Global solid tumors drugs market: YoY revenue and growth based on drug class 2015-2020 ($ billions)
Exhibit 21: Stages of breast cancer based on tumor size and extent of metastasis
Exhibit 22: Classification of breast cancer based on genetic makeup of tumor cells
Exhibit 23: Treatment regimen for breast cancer
Exhibit 24: Product offerings for breast cancer drugs market
Exhibit 25: Global breast cancer drugs market 2015-2020 ($ billions)
Exhibit 26: Product offerings for global NHL drugs market
Exhibit 27: Global NHL drugs market 2015-2020 ($ billions)
Exhibit 28: Product offerings for global colorectal cancer drugs market
Exhibit 29: Global colorectal cancer drugs market 2015-2020 ($ billions)
Exhibit 30: Products offerings for global NSCLC drugs market
Exhibit 31: Global NSCLC drugs market 2015-2020 ($ billions)
Exhibit 32: Product offerings for global prostate cancer drugs market
Exhibit 33: Global prostate cancer drugs market 2015-2020 ($ billions)
Exhibit 34: Product offerings for global kidney cancer drugs market
Exhibit 35: Global kidney cancer drugs market 2015-2020 ($ billions)
Exhibit 36: Product offerings for global retinoblastoma drugs market
Exhibit 37: Global retinoblastoma drugs market 2015-2020 ($ billions)
Exhibit 38: Product offerings for global cervical cancer market
Exhibit 39: Global cervical cancer market 2015-2020 ($ billions)
Exhibit 40: Product offerings for global melanoma drugs market
Exhibit 41: Global melanoma drugs market 2015-2020 ($ billions)
Exhibit 42: Products offerings for global gastric cancer drugs market
Exhibit 43: Global gastric cancer drugs market 2015-2020 ($ billions)
Exhibit 44: Products offerings for global pancreatic cancer drugs market
Exhibit 45: Global pancreatic cancer drugs market 2015-2020 ($ billions)
Exhibit 46: Products offerings for global ovarian cancer drugs market
Exhibit 47: Global ovarian cancer drugs market 2015-2020 ($ billions)
Exhibit 48: Product offerings for global liver cancer drugs market
Exhibit 49: Global liver cancer drugs market 2015-2020 ($ billions)
Exhibit 50: Products offerings for global HL drugs market
Exhibit 51: Global HL drugs market 2015-2020 ($ millions)
Exhibit 52: Products offerings for global glioblastoma multiforme drugs market
Exhibit 53: Global glioblastoma multiforme drugs market 2015-2020 ($ millions)
Exhibit 54: Global solid tumors drugs market by geography 2015
Exhibit 55: Global solid tumors drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 56: Global solid tumors drugs market revenue by geography 2015-2020
Exhibit 57: Solid tumors drugs market in Americas 2015-2020 ($ billions)
Exhibit 58: Solid tumors drugs market in EMEA 2015-2020 ($ billions)
Exhibit 59: Solid tumors drugs market in APAC 2015-2020 ($ billions)
Exhibit 60: Global solid tumors drugs market: YoY revenue and growth based on geography 2015-2020 ($ billions)
Exhibit 61: Global incidence of solid tumor types 2015
Exhibit 62: Global mortality of solid tumor types 2015
Exhibit 63: Impact of drivers
Exhibit 64: Patent expiries of major cancer monoclonal antibodies by 2020
Exhibit 65: Average cost comparison of Herceptin 2014
Exhibit 66: Impact of drivers and challenges
Exhibit 67: Expected combination regimen launches in oncology
Exhibit 68: YoY Sales comparison of top drugs 2013-2015 ($ billions)
Exhibit 69: Ranking of major vendors for global solid tumors drugs market
Exhibit 70: Market share analysis of global solid tumors drugs market 2015
Exhibit 71: F. Hoffmann-La Roche: YoY growth and revenue generated from total product sales of MabThera/Rituxan (oncology indications) 2013-2015 ($ billions)
Exhibit 72: MabThera/Rituxan geographic segmentation by revenue 2015
Exhibit 73: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Avastin 2013-2015 ($ billions)
Exhibit 74: F. Hoffmann-La Roche: Geographic segmentation of Avastin by revenue 2015
Exhibit 75: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Herceptin 2013-2015 ($ billions)
Exhibit 76: F. Hoffmann-La Roche: Geographical segmentation of Herceptin 2015
Exhibit 77: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Perjeta 2013-2015 ($ billions)
Exhibit 78: F. Hoffmann-La Roche: Geographical segmentation of Perjeta 2015
Exhibit 79: F. Hoffmann-La Roche: Revenue generated from net product sales of Kadcyla 2013-2015 ($ millions)
Exhibit 80: F. Hoffmann-La Roche: Geographical segmentation of Kadycla 2015
Exhibit 81: F. Hoffmann-La Roche: Revenue generated from net product sales of Tarceva 2013-2015 ($ billions)
Exhibit 82: F. Hoffmann-La Roche: Geographical segmentation of Tarceva 2015
Exhibit 83: F. Hoffmann-La Roche: Key takeaways
Exhibit 84: Novartis: YoY revenue and growth rate of Gleevec 2013-2015 ($ billions)
Exhibit 85: Novartis: YoY revenue and growth rate of Sandostatin 2013-2015 ($ billions)
Exhibit 86: Novartis: YoY revenue and growth rate of Sandostatin 2013-2015 ($ billions)
Exhibit 87: Novartis: Key takeaways
Exhibit 88: Celgene: YoY revenue and growth rate of Revlimid 2013-2015 ($ billions)
Exhibit 89: Celgene: YoY revenue and growth rate of Abraxane 2013-2015 ($ millions)
Exhibit 90: Celgene: YoY revenue and growth rate of Istodax 2013-2015 ($ millions)
Exhibit 91: Celgene: YoY revenue and growth rate of Pomalyst 2013-2015 ($ millions)
Exhibit 92: Celgene: YoY revenue and growth rate of Pomalyst 2013-2015 ($ millions)
Exhibit 93: Celgene: Key takeaways
Exhibit 94: Johnson & Johnson: YoY revenue comparison of Zytiga 2013-2015 ($ billions)
Exhibit 95: Johnson & Johnson: YoY revenue comparison of Velcade 2013-2015 ($ billions)
Exhibit 96: Johnson & Johnson: YoY revenue comparison of Imbruvica 2014-2015 ($ millions)
Exhibit 97: Key takeaways
Exhibit 98: Pfizer: YoY revenue and growth rate of Sutent 2013-2015 ($ billions)
Exhibit 99: Pfizer: YoY revenue and growth rate of Xalkori 2013-2015 ($ millions)
Exhibit 100: Pfizer: YoY revenue and growth rate of Inlyta 2013-2015 ($ millions)
Exhibit 101: Key takeaways
Exhibit 102: BMS: YoY revenue and growth rate of Erbitux 2013-2015 ($ millions)
Exhibit 103: BMS: YoY revenue and growth rate of Sprycel 2013-2015 ($ billions)
Exhibit 104: Key takeaways
【レポート販売概要】
■ タイトル：固形腫瘍治療薬の世界市場2016-2020■ 英文：Global Solid Tumors Drugs Market 2016-2020
■ 発行日：2016年6月24日
■ 調査会社：Technavio
■ 商品コード：IRTNTR9801
■ 調査対象地域：グローバル
- 飼料プレミックスの世界市場2018-2022112 pages, October 2018 About this market The increase in capacity expansions and new plants will boost the market growth. The rise in demand for food premixes has been attracting producers to expand their food capacities. Hence, the market has gone many expansions. Technavio’s analysts have predicted that the feed premix market will register a CAGR of more than 3% by 2022. Market Overview Increas …
- 世界の自動車クランクシャフト市場2015The Global Automotive Crankshaft Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Automotive Crankshaft industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Crankshaft market analysis is provided for the international markets including deve …
- ポリウレタンフォームの世界市場2016-2020：硬質ポリウレタンフォーム、軟質ウレタンフォーム、スプレーウレタンフォームAbout Polyurethane Foam Polyurethane is a polymer composed of organic units joined by urethane links. Most polyurethanes are thermosetting polymers that do not melt when heated. Polyurethane polymers are commonly formed by reacting a di- or polyisocyanate with a polyol. The isocyanates and polyols used to make polyurethanes contain an average of two or more functional groups per molecule. Technavi …
- グローバル軍事航空市場（2014-2024）：動向、開発、課題Synopsis This report offers readers insights into technological developments in the Military Aviation market, as well as detailed analysis of the changing preferences of military forces around the world. It also identifies the current trends in the changing industry structure and the challenges faced by industry participants. Summary Technological Developments in the global Military Aviation inclu …
- IaaSソリューションの世界市場予測（～2020）The infrastructure as a service (IaaS) market is expected to grow from USD 15.79 Billion in 2015 to USD 56.05 Billion by 2020, at a CAGR of 29.0%. Several factors such as faster implementation, scalability, flexibility, and agility provided by the service; increasing market competition; and increasing demand for reducing investment on IT infrastructures, hardware, and hiring skilled resources are …
- デジタルX線装置の世界市場：インターベンショナルX線装置、マンモグラフィーX線装置、歯科用X線装置、汎用X線装置、動物用X線装置、モバイルCアームAbout Digital X-ray Systems Digital X-ray systems are used for diagnosing and treatment of diseases by creating and recording images. The X-ray images captured using a digital system are no different from that of screen-film radiography. In a digital system, screen-film detectors and sensors generate the digital image. Digital detectors allow full implementation of image archiving and communicatio …
- Iberdrola, S.A.：石油・ガスバリューチェーン分析レポート2013Iberdrola, S.A. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Iberdrola, S.A." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Iberdrola, S.A.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the compan …
- 世界のEメールアーカイビング市場動向（2012-2016）TechNavio's analysts forecast the Global E-mail Archiving market to grow at a CAGR of 18.69 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for e-discovery. The Global E-mail Archiving market has also been witnessing an increasing adoption of cloud-based solutions. However, the availability of open source solutions could pose a …
- PTFEマイクロパウダーの世界市場：印刷インク、熱可塑性樹脂、塗料、グリース/潤滑剤、エラストマー用途PTFE micro powder or micronized PTFE is made from virgin polytetrafluoroethylene resin or recycled PTFE scrap. PTFE is irradiated using technologies, such as electron beam irradiation or thermal degradation, followed by grinding or milling to form low molecular weight PTFE micro powders that are used as additives for various applications. Micronized PTFE caters to an entirely different market from …
- グローバル鉱業の景況感レポート（2015年上半期）Summary “Mining Business Confidence Report H1 2015” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the mining industry. This report also examines executive opinions with regards to the current and future state of the economy and its effect on the industry. It analyzes …
- 有機過酸化物の世界市場：ジアシルペルオキシド、ケトンペルオキシド、ペルオキシエステル、過炭酸塩、ジアルキルペルオキシド、パーオキシケタール、ヒドロペルオキシドChemical & plastic, coating adhesives & elastomers, paper & textiles, detergents, personal care, and others are the key applications of organic peroxides. Chemical & plastic and coating adhesives & elastomers together accounted for the major share of the organic peroxides market in 2014. The increasing demand from chemical industry and bleaching applications in China and India, and advancement in …
- 世界のデジタルレコーディング・ミュージック市場動向（2012-2016）TechNavio's analysts forecast the Global Digital Recording Music market to grow at a CAGR of 12.05 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in initiatives to curb piracy. The Global Digital Recording Music market has also been witnessing an increase in the adoption of cloud services. However, the decrease in consumer spending coul …
- 工場自動化ソリューションの世界市場2016-2020About Plant Automation Solutions Plant automation encompasses various technologies starting from acquisition of raw materials to distribution of final products, and represents a revolution in the manufacturing industry. An automation control solution enables organizations in the process and discrete industries to increase the overall efficiency and functioning. It enables collection of data from f …
- 世界における小型自動車用ルーフシステム市場動向と予測（～2029）This latest just-auto report edition offers a global review of the OE roof systems sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE roof systems market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prosp …
- Android device base database by Vendor, Handset Model, Region and Country Q3 2011With global shipments increasing by 280 % in 2011, android smartphones have attained a global smartphone market share of 32 % in a relatively short span of time from just 13 % in 2010. Google recently announced in its Q3 2011 conference call that the total number of android activations had surpassed 190 million, up from 135 million in Q2 2011. In particular, with the entry of Chinese and Indian ve …
